-
1.
公开(公告)号:US11783941B2
公开(公告)日:2023-10-10
申请号:US17523527
申请日:2021-11-10
Applicant: ABBOTT DIABETES CARE INC.
Inventor: Gary Alan Hayter , Andrew H. Naegeli
CPC classification number: G16H40/63 , G06K7/10009 , G16B50/00 , G16B50/30 , G16H40/67
Abstract: Methods, devices, and kits are provided for determining a compatibility of one or more devices in an analyte monitoring system.
-
2.
公开(公告)号:US20230157643A1
公开(公告)日:2023-05-25
申请号:US18150996
申请日:2023-01-06
Applicant: ABBOTT DIABETES CARE INC.
Inventor: Gary Alan Hayter , Nathan Christopher Crouther , Michael Love , Erwin Satrya Budiman , Daniel Milfred Bernstein
CPC classification number: A61B5/7246 , A61B5/1118 , A61B5/14532 , A61B5/4839 , A61B5/7275 , A61B5/4866 , G16B40/10 , G16H40/63 , A61B5/0022 , A61B5/1451 , A61B5/024
Abstract: Method, device and system for providing consistent and reliable glucose response information to physiological changes and/or activities is provided to improve glycemic control and health management.
-
公开(公告)号:US20220359074A1
公开(公告)日:2022-11-10
申请号:US17864931
申请日:2022-07-14
Applicant: ABBOTT DIABETES CARE INC.
Inventor: Daniel Milfred Bernstein , Martin J. Fennell , Mark Kent Sloan , Michael Love , Lei He , Christopher Allen Thomas , Udo Hoss , Benjamin Jay Feldman , Kenneth J. Doniger , Gary Ashley Stafford , Gary Alan Hayter , Phillip Yee , Namvar Kiaie , Jean-Pierre Cole , Marc Barry Taub , Louis George Pace , Jeffery Mario Sicurello
IPC: G16H40/67 , G01N33/487 , A61B5/00 , A61B5/145 , A61B5/1486 , A61B5/01 , G16H40/63
Abstract: Methods and devices to monitor an analyte in body fluid are provided. Embodiments include continuous or discrete acquisition of analyte related data from a transcutaneously positioned in vivo analyte sensor automatically or upon request from a user. The in vivo analyte sensor is coupled to an electronics unit holding a memory with instruction to cause processing circuitry to initiate a predetermined time period that is longer than a predetermined life of the sensor, during the predetermined time period, convert signals from the sensor related to glucose to respective corresponding glucose levels, without relying on any post-manufacture independent analyte measurements from a reference device, and at the expiration of the predetermined time period, disable, deactivate, or cease use of one or more feature.
-
公开(公告)号:US20220233110A1
公开(公告)日:2022-07-28
申请号:US17720969
申请日:2022-04-14
Applicant: ABBOTT DIABETES CARE INC.
Inventor: Wesley Scott Harper , Annie C. Tan , Timothy Christian Dunn , Mark Kent Sloan , Kenneth J. Doniger , Michael Love , Phillip Yee , Gary Alan Hayter , R. Curtis Jennewine , Glenn Howard Berman
IPC: A61B5/145
Abstract: Embodiments described herein relate to an analyte monitoring device having a user interface with a display and a plurality of actuators. The display is configured to render a plurality of display screens, including a home screen and an alert screen. The home screen is divided into a plurality of simultaneously displayed panels, with a first panel displays a rate of change of continuously monitored analyte levels in interstitial fluid, a second panel simultaneously displays a current analyte level and an analyte trend indicator, and a third panel displays status information of a plurality of components of the device. When an alarm condition is detected, the display renders the alert screen in place of the home screen, the alert screen displaying information corresponding to the detected alarm condition. Furthermore, the actuators are configured to affect further output of the analyte monitoring device corresponding to the detected condition.
-
5.
公开(公告)号:US20220211303A1
公开(公告)日:2022-07-07
申请号:US17700375
申请日:2022-03-21
Applicant: ABBOTT DIABETES CARE INC.
Inventor: Gary Alan Hayter , Kenneth J. Doniger , Erwin Satrya Budiman , Songbiao Zhang , John Charles Mazza
IPC: A61B5/1495 , A61B5/145 , G01N27/327 , A61B5/1468 , A61B5/1473 , A61B5/00
Abstract: Method and apparatus for providing calibration of analyte sensor including applying a control signal, detecting a measured response to the control signal, determining a variance in the detected measured response, and estimating a sensor sensitivity based on the variance in the detected measured response is provided
-
6.
公开(公告)号:US11125592B2
公开(公告)日:2021-09-21
申请号:US16040451
申请日:2018-07-19
Applicant: Abbott Diabetes Care Inc.
Inventor: Gary Alan Hayter , Geoffrey V. McGarraugh , Andrew H. Naegeli , John Charles Mazza , Benjamin Jay Feldman
IPC: A61B5/145 , G16H15/00 , G01D18/00 , G16H40/63 , A61B5/1473 , A61B5/00 , G06F19/00 , A61B5/1495 , G01N33/48 , G16H40/40
Abstract: Methods and apparatus for providing data processing and control for use in a medical communication system are provided.
-
7.
公开(公告)号:US20210231639A1
公开(公告)日:2021-07-29
申请号:US17228531
申请日:2021-04-12
Applicant: ABBOTT DIABETES CARE INC.
Inventor: Gary Alan Hayter , Geoffrey V. McGarraugh , Andrew H. Naegeli , John Charles Mazza , Benjamin Jay Feldman
IPC: G01N33/49 , A61B5/145 , A61B5/1473 , A61B5/1495 , G16H40/67 , G16H20/10 , G16H10/40
Abstract: Methods for data processing and control for a medical communication system are provided, including determining a sensitivity value for each sensor of a batch of in vivo analyte sensors; determining a sensitivity variation for each sensor of the batch; determining a mean sensitivity based on the sensitivity value determined for each sensor of the batch when it is determined that the determined sensitivity variation does not exceed a tolerance threshold level; associating a sensor code with each sensor of the batch of in vivo analyte sensors when the mean sensitivity is within a predetermined sensitivity range, wherein the sensor code associated with each sensor is based on a characteristic of the associated sensor; and storing the sensor code associated with at least one sensor of the batch configured to generate signals corresponding to monitored analyte level in a memory of a data processing device associated with the sensor.
-
公开(公告)号:US20210077033A1
公开(公告)日:2021-03-18
申请号:US17107097
申请日:2020-11-30
Applicant: ABBOTT DIABETES CARE INC.
Inventor: Wesley Scott Harper , Annie C. Tan , Timothy Christian Dunn , Mark Kent Sloan , Kenneth J. Doniger , Michael Love , Phillip Yee , Gary Alan Hayter , R. Curtis Jennewine , Glenn Howard Berman
Abstract: Embodiments described herein relate to an analyte monitoring device having a user interface with a display and a plurality of actuators. The display is configured to render a plurality of display screens, including a home screen and an alert screen. The home screen is divided into a plurality of simultaneously displayed panels, with a first panel displays a rate of change of continuously monitored analyte levels in interstitial fluid, a second panel simultaneously displays a current analyte level and an analyte trend indicator, and a third panel displays status information of a plurality of components of the device. When an alarm condition is detected, the display renders the alert screen in place of the home screen, the alert screen displaying information corresponding to the detected alarm condition. Furthermore, the actuators are configured to affect further output of the analyte monitoring device corresponding to the detected condition.
-
9.
公开(公告)号:US20200275869A1
公开(公告)日:2020-09-03
申请号:US16875754
申请日:2020-05-15
Applicant: Abbott Diabetes Care Inc.
Inventor: Gary Alan Hayter
IPC: A61B5/145 , A61B5/1473 , A61B5/1495 , A61B5/00 , G16H20/10 , G16H10/40
Abstract: Methods and apparatus for providing data processing and control for use in a medical communication system are provided.
-
公开(公告)号:US20200121264A1
公开(公告)日:2020-04-23
申请号:US16664083
申请日:2019-10-25
Applicant: Abbott Diabetes Care Inc.
Inventor: Wesley Scott Harper , Annie C. Tan , Timothy Christian Dunn , Mark Kent Sloan , Kenneth J. Doniger , Michael Love , Phillip Yee , Gary Alan Hayter , R. Curtis Jennewine , Glenn Howard Berman
Abstract: Embodiments described herein relate to an analyte monitoring device having a user interface with a display and a plurality of actuators. The display is configured to render a plurality of display screens, including a home screen and an alert screen. The home screen is divided into a plurality of simultaneously displayed panels, with a first panel displays a rate of change of continuously monitored analyte levels in interstitial fluid, a second panel simultaneously displays a current analyte level and an analyte trend indicator, and a third panel displays status information of a plurality of components of the device. When an alarm condition is detected, the display renders the alert screen in place of the home screen, the alert screen displaying information corresponding to the detected alarm condition. Furthermore, the actuators are configured to affect further output of the analyte monitoring device corresponding to the detected condition.
-
-
-
-
-
-
-
-
-